Showing results (81-90 of 518) with videos related to
Sort By:
Pageof 52
The Journal of Experimental Medicine|April 1, 1983
Antiidiotypes against anti-H-2 monoclonal antibodies. V. In vivo antiidiotype treatment induces idiotype-specific helper T cellsH Auchincloss, J A Bluestone, D H SachsInternational Reviews of Immunology|December 2, 2005
Achieving antigen-specific tolerance in diabetes: regulating specificallyWei Chen, Jeffrey A Bluestone, Kevan C HeroldCold Spring Harbor Perspectives in Medicine|February 10, 2025
Type 1 Diabetes: Advances in Understanding and Treatment 100 Years after the Discovery of InsulinJeffrey A Bluestone, Kevan C Herold, Lori SusselThe Journal of Experimental Medicine|August 1, 1985
Evidence for a regulatory idiotypic network in the in vivo response to H-2 antigensR Rabinowitz, J A Bluestone, D H SachsNature Reviews. Immunology|December 8, 2019
Treg cell-based therapies: challenges and perspectivesCaroline Raffin, Linda T Vo, Jeffrey A BluestoneTrends in Immunology|March 14, 2021
Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting CytokinesJee Hye Kang, Jeffrey A Bluestone, Arabella YoungJournal of Molecular Cell Biology|December 16, 2011
CD4(+)Foxp3(+) regulatory T cell therapy in transplantationQizhi Tang, Jeffrey A Bluestone, Sang-Mo KangThe Journal of Experimental Medicine|June 1, 1993
Tolerance of T cell receptor gamma/delta cells in the intestineT A Barrett, Y Tatsumi, J A BluestoneAmerican Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2007
CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospectsS M Kang, Q Tang, J A BluestoneJournal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
B7-independent inhibition of T cells by CTLA-4Shunsuke Chikuma, Abul K Abbas, Jeffrey A BluestonePageof 52